TORL BioTherapeutics Strengthens Leadership with CEO Appointment of Aran Maree
TORL BioTherapeutics LLC (TORL), a clinical stage oncology focused biotechnology company, announced a leadership transition to position the Company for its next phase of growth. Effective as of May 1, 2026, Aran Maree, M.D., is appointed Chief Executive Officer (CEO) and Board Member. Dr. Maree succeeds Mark Alles, wh…
